INTRODUCTION {#S1}
============

Erythropoiesis occurs in a series of stages, with early developmental stages marked by the commitment of multilineage progenitor cells into erythroid progenitors with subsequent cellular proliferation and differentiation, followed by terminal erythroid differentiation, enucleation, and reticulocyte maturation into mature erythrocytes ([@R29]). Mature mammalian erythrocytes are unique among the vertebrates, lacking nuclei and cellular organelles. An enucleate erythrocyte is a trait attributed to the organismal need to develop strategies to increase oxygen-carrying capacity ([@R90]; [@R91]; [@R61]) to adapt to increased oxygen demands ([@R36]; [@R37],[@R38]; [@R76]). Thus, mature erythrocytes cannot undergo cell division or perform RNA synthesis, and they have a limited ability for self-repair.

Throughout the process of erythropoiesis, erythroid cells exhibit patterns of gene expression that direct a precise ensemble of proteins required for cellular structure and function. During terminal erythroid differentiation, erythroblasts decrease in size, nuclear chromatin condenses, cells produce large amounts of hemoglobin, membranes undergo reorganization, cell volume and surface area decrease, and enucleation occurs ([@R41]; [@R111]). To meet the requirements for these precise cellular functions, hundreds of genes change their patterns of expression between each stage of terminal erythroid differentiation ([@R4]). In nonerythroid cells, epigenetic regulation has been shown to establish patterns of gene expression for developmental and stage-specific cell types via the differential utilization of gene regulatory elements ([@R96]; [@R43]; [@R109]).

Identification and characterization of the epigenomic landscape and its contribution to the control of programs of gene expression in highly specialized human erythroid cells will allow a better understanding of erythropoiesis by revealing the temporal dynamics of regulatory element usage ([@R79]; [@R30]; [@R7]; [@R48]). In addition, linking regions with appropriate chromatin accessibility and/or DNA methylation to relevant SNPs will provide mechanistic insights into erythroid cell phenotypic variation in normal individuals ([@R108]; [@R81]; [@R102]; [@R113]; [@R110]; [@R118]; [@R32]; [@R49]; [@R23]; [@R27]; [@R78]; [@R50]; [@R22]; [@R101]) and into pathways dysregulated in inherited and acquired diseases of the erythrocyte ([@R9], [@R10]; [@R88]) by capturing the regulatory landscapes central to human health and disease ([@R77]).

In this report, we define and correlate genome-wide chromatin accessibility, DNA methylation, and genomic organization with transcriptome analyses in highly purified populations of primary human erythroid cells at distinct stages of erythroid development and differentiation. These epigenomic and expression data are integrated with *cis*-genetic variants that are associated with phenotypic variation in erythroid cell traits and with acquired and inherited diseases of the erythrocyte.

Widespread changes in stage-specific patterns of chromatin accessibility and DNA methylation occurred, marking dynamic regulatory elements associated with patterns of gene expression influencing erythroid cell development and differentiation. Stage-specific patterns of chromatin accessibility were linked to genetic loci associated with erythroid cell traits and inherited erythroid diseases. Comparative analyses revealed a new conceptual framework for understanding terminal erythroid differentiation. Indistinguishable from other cells via morphologic characteristics, the epigenome of differentiating human erythroid cells defines a unique subset of highly specialized cells that are vastly dissimilar from all other hematopoietic and nonhematopoietic cell types. These epigenomes direct a cellular program that ultimately produces the highly specialized morphologically and functionally distinct mature erythrocyte. These epigenomic and transcriptome data are important tools to study human erythropoiesis and will be of benefit to a wide range of investigators studying inherited and acquired diseases of the erythrocyte.

RESULTS {#S2}
=======

Gene Expression during Erythropoiesis {#S3}
-------------------------------------

A strategy using fluorescence-activated cell sorting (FACS)-based methods to purify morphologically and functionally discrete populations of cells at differing stages of erythroid development and differentiation was used to obtain pure populations of erythroid cells at distinct developmental and differentiation stages ([@R4]; [@R65]; [@R20]).

RNA was prepared from umbilical cord-derived CD34^+^ hematopoietic stem and progenitor cells (HSPCs) and from BFU-E (burst-forming unit erythroid) and CFU-E (colony-forming unit erythroid) cells obtained after FACS sorting of cells derived from the erythroid cell culture of umbilical cord-derived HSPCs ([Figure S1](#SD1){ref-type="supplementary-material"}) ([@R4]; [@R65]). RNA sequencing (RNA-seq) was performed and a series of unbiased, stage-specific transcriptomes was prepared.

Analysis of these progenitor cell transcriptomes and previously published transcriptomes from umbilical cord-derived proerythroblast through polychromatic erythroblast stage cells from terminal erythroid differentiation ([@R4]; [@R65]) revealed tight clustering of transcriptomes from differing stages, even between biologically different replicates ([Figure S2](#SD1){ref-type="supplementary-material"}). There are marked differences between stages, with both shared and dissimilar gene expression profiles defining each stage (data not shown). There are numerous significant (false discovery rate \[FDR\] \< 0.05; [Table S1](#SD2){ref-type="supplementary-material"}) temporal changes in gene expression, with each developmental (BFU-E, CFU-E) and differentiation (proerythroblast to orthochromatic erythroblast) stage exhibiting unique transcriptomes. Gene Ontology analyses reveal varying patterns of expression enriched for genes of differing function ([Figure S3](#SD1){ref-type="supplementary-material"}). These data indicate that differing programs of regulation likely control these varying stage-specific expression patterns.

Changes in Chromatin Accessibility throughout Erythropoiesis {#S4}
------------------------------------------------------------

Nucleosome-depleted regions of open, accessible chromatin are found around the transcription start sites (TSSs) of active genes ([@R103]) and mark important regulatory elements, including promoters, enhancers, and insulators ([@R103]; [@R42]; [@R51]; [@R104]; [@R112]). The study of chromatin accessibility has yielded many insights into erythroid gene regulation. For instance, the identification of DNaseI hypersensitive sites (DHSs), regions of DNA sensitive to digestion because of an "open" chromatin state, led to the identification of the globin gene locus control region (LCR) and an erythroid enhancer in the *BCL11A* gene linked to hemoglobin F levels, now a target of treatment strategies to treat β-thalassemia and sickle cell disease ([@R64]; [@R67]; [@R10]). We used the assay for transposase-accessible chromatin using sequencing (ATAC-seq), a rapid, sensitive technique for identifying sites of open chromatin on a genome-wide scale ([@R25]). We applied this technique to human erythroid cells cultured from umbilical cord-derived HSPCs at differing stages of erythroid development and differentiation using FACS-based methods to purify morphologically and functionally discrete populations of cells ([Figure S1](#SD1){ref-type="supplementary-material"} and [S4](#SD1){ref-type="supplementary-material"}) ([@R4]; [@R65]; [@R20]). Sequence and read mapping data are provided in [Figure S2](#SD1){ref-type="supplementary-material"}). Principal-component analyses revealed stage-dependent patterns that ordered as expected during erythropoiesis ([Figure S2](#SD1){ref-type="supplementary-material"}).

We detected changes in chromatin accessibility across erythroid development and differentiation, with sites of chromatin accessibility gained or lost during erythropoiesis. Examples of changes in the patterns of chromatin accessibility are shown at the β-globin-like gene cluster and *BCL11A* gene locus, where ATAC peaks localize at gene promoters and known erythroid cell enhancers and regulatory elements ([Figures 1A](#F1){ref-type="fig"} and [1B](#F1){ref-type="fig"}). Large numbers of ATAC peaks were acquired during the developmental stages of erythropoiesis, between HSPC to BFU-E, BFU-E to CFU-E, and notably from CFU-E to proerythroblast stage (ProE), while large numbers of ATAC peaks were lost between HSPC and BFU-E and late basophilic erythroblast (LBaso) to polychromatic erythroblast stages ([Figure 1C](#F1){ref-type="fig"}). For unknown reasons, there were no large changes in ATAC peaks between three of the four transitions during terminal erythroid differentiation. Analysis of ATAC peak localization revealed the proportion of nonpromoter peaks (intergenic + 5′ and 3′ distal peaks) decreased by stage, from BFU-E throughout erythroid development and differentiation, while the proportion of promoter (≤1,000 bp from the TSS) peaks increased ([Figure 1D](#F1){ref-type="fig"}). To assess whether these changes affected putative enhancers or other regulatory elements, we compared nonpromoter (\>1,000 and \<50,000 bp from the TSS) ATAC peaks lost during erythroid development and differentiation with genomic data from human HSPC and mixed populations of cultured human erythroblasts ([@R113], [@R114]; [@R99]). Of the lost nonpromoter ATAC peaks, 28% were putative active enhancers (defined as the presence of monomethyl histone 3 lysine 4 \[H3K4me1\] and acetyl histone 3 lysine 27 \[H3K27Ac\] and the absence of trimethyl histone 3 lysine 27 \[H3K27me3\] in HSPCs \[p ≤ 0.0001\]), suggesting enhancer decommissioning during erythropoiesis. In parallel, 10% of the lost nonpromoter ATAC peaks exhibited H3K27 trimethylation in erythroblasts (p ≤ 0.0001). Eleven and nine percent of the lost nonpromoter ATAC peaks had co-localizing CTCF or cohesin^SA-1^ respectively (both p ≤ 0.0001).

Analyses of associated functional terms with differential ATAC peaks revealed enrichment for erythroid-related terms, particularly for regions showing increased chromatin accessibility in the transitions from BFU-E to CFU-E, CFU-E to proerythroblast, and late basophilic erythroblast to polychromatic erythroblast stages ([Table S2](#SD3){ref-type="supplementary-material"}).

Erythroid Cells Exhibit a Distinct Pattern of Chromatin Accessibility {#S5}
---------------------------------------------------------------------

One goal of our study was to identify regions of open chromatin unique to erythroid cells, as markers of critical erythroid-specific regulatory elements. To do this, we examined patterns of chromatin accessibility in erythroid cells and compared them to patterns in other hematopoietic and nonhematopoietic cell types. To separate direct promoter-associated sites and nonpromoter-associated sites, we analyzed chromatin accessibility at both promoter and nonpromoter locations, respectively, by erythroid-specific stage ([Figure 2](#F2){ref-type="fig"}). Many (4,386) erythroid-specific nonpromoter sites exhibiting distinct patterns of chromatin accessibility compared to other hematopoietic cell types were identified. An example of erythroid-specific ATAC peaks at the hexokinase-1 (*HK1*) gene locus is shown in [Figure 2A](#F2){ref-type="fig"}. Regions of chromatin accessibility representing stages of terminal erythroid differentiation clustered together tightly and were the most different from all of the other hematopoietic cell types ([Figures 2B](#F2){ref-type="fig"} and [2C](#F2){ref-type="fig"}). Functional analyses using the genomic regions enrichment of annotations tool (GREAT) algorithm ([@R73]) of nonpromoter differential ATAC peaks revealed enrichment for erythroid-related terms, particularly terms related to red blood cell phenotypic traits ([Figure 2D](#F2){ref-type="fig"}). Erythroid cell promoter sites exhibited similar distinctive patterns of chromatin accessibility with functional correlates linked to erythroid cell phenotypes ([Table S2](#SD3){ref-type="supplementary-material"}; data not shown). The stages of terminal erythroid differentiation clustered together tightly and were the most different from all of the other hematopoietic cell types.

The distinct pattern of chromatin accessibility of cells from terminal differentiation was even more apparent when nonhematopoietic cells were included in the comparison, in which they widely separate in both principal-component analysis and hierarchical clustering analysis ([Figures 2E](#F2){ref-type="fig"} and [2F](#F2){ref-type="fig"}). These observations support the hypothesis that erythroid cells possess a specialized pattern of regulatory elements to direct patterns of gene expression that define stage-specific cellular phenotype.

Correlation of ATAC Peaks and Gene Expression {#S6}
---------------------------------------------

Regions of chromatin accessibility found at gene promoters and at linked regulatory elements are expected to be associated with expressed, actively transcribing genes. To assess the relation between chromatin accessibility and gene expression, we correlated promoter-associated and nonpromoter-associated ATAC peaks with the expression of nearby genes. While the expression of linked genes with an ATAC peak at only the promoter would be expected to be lower than the expression of genes with an ATAC peak in both the promoter and at a nearby nonpromoter site, this was not observed in erythroid progenitor cells (HSPC p = 0.38, BFU-E p = 1.0, and CFU-E p = 0.14; [Figure 3A](#F3){ref-type="fig"}). However, the expression of linked genes with an ATAC peak at both the promoter and at a nearby nonpromoter site was higher in cells undergoing terminal erythroid differentiation (proerythroblasts, early and late basophilic erythroblasts, orthochromatic and polychromatic erythroblasts, all p \< 2.2e--16). The association of highly expressed erythroid genes with increasing numbers of nonpromoter-associated ATAC peaks during terminal erythroid differentiation suggests the acquisition of erythroid enhancers ([Figure S5](#SD1){ref-type="supplementary-material"}). When correlating the amount of gene expression assayed by RNA-seq transcripts per million reads (TPM) and the amount of open chromatin determined by ATAC-seq reads per kilobase per million reads (RPKM), the correlation was stronger in terminal erythropoiesis than in progenitors and was stronger in promoter than in nonpromoter regions ([Figure S5](#SD1){ref-type="supplementary-material"}).

A pattern of chromatin opening in one stage followed by the acquisition of linked gene expression in subsequent stages, while not uniform, was common throughout erythroid development and differentiation. In the transitions from HSPC to BFU-E, BFU-E to CFU-E, and CFU-E to proerythroblast, the gene expression of linked genes that lost ATAC peaks was significantly lower than the expression of linked genes that gained ATAC peaks (p= 1.8e--5, 2.2e--16, and 2.2e--16, respectively; [Figure 3B](#F3){ref-type="fig"}). For example, at the single-gene level, promoter and nonpromoter-associated ATAC peaks that are not present in erythroid progenitor cells are acquired during erythroid differentiation, paralleling the onset of detectable gene expression at the *GLUT1* (*SLC2A1*) Ggene locus ([Figure 3C](#F3){ref-type="fig"}).

Open chromatin regions identified by ATAC-seq or DNaseI hypersensitive mapping are enriched for known and novel cell-type biologically-relevant transcription factor binding motifs ([@R75]; [@R93]). We performed motif finding using the hypergeometric optimization of motif enrichment (HOMER) algorithm to determine whether specific motifs are enriched during erythropoiesis ([@R44]). In HSPCs and at all erythroid stages, the top enriched motif was CTCF, similar to other reports in which the CTCF is the most common motif found at sites of open chromatin ([Table S3](#SD4){ref-type="supplementary-material"}) ([@R112]).

When analyzing differentially acquired ATAC peaks between stages, CEBPα, ETS, GATA, and RUNX were the top motifs acquired between HSPC and BFU-E cells; GATA, AP1/NFE2, KLF, and RUNX were the top motifs acquired between BFU-E and CFU-E cells; and GATA, KLF, CCAAT, and CTCF were the top motifs acquired between CFU-E and proerythroblast cells ([Figure 4A](#F4){ref-type="fig"}; [Table S4](#SD5){ref-type="supplementary-material"}). When examining terminal erythroid differentiation (proerythroblast to orthochromatic erythroblast), the acquired ATAC peaks had high amounts of NFE2 and KLF1 consensus motifs, paralleling the increases in NFE2 and KLF1 gene and protein expression ([Figures 4B](#F4){ref-type="fig"} and [4C](#F4){ref-type="fig"}; [Table S1](#SD2){ref-type="supplementary-material"}) ([@R34]). In contrast, ATAC peaks that decrease from proerythroblast to orthochromatic erythroblast stages have high amounts of GATA consensus motifs (46%; [Table S4](#SD5){ref-type="supplementary-material"}). This change parallels the decrease in GATA1 expression between these stages of differentiation ([Figures 4B](#F4){ref-type="fig"} and [4C](#F4){ref-type="fig"}; [Table S1](#SD2){ref-type="supplementary-material"}). The decrease in GATA1 expression led us to examine whether GATA motifs were changing in other ATAC peaks, including those that do not change during terminal erythroid differentiation.

Analysis of differential digital footprints obtained with the HINT (Hmm-based identification of transcription factor footprints) algorithm in the complete set of ATAC peaks revealed that GATA footprints decreased globally (p = 0.033), not just in the subset of decreasing ATAC peaks, as terminal erythroid differentiation progressed ([Figure S6A](#SD1){ref-type="supplementary-material"}) ([@R66]). These data suggest that GATA1 activity may lose importance in the late stages of terminal erythroid differentiation.

A smaller number of erythroid cell type-specific ATAC peaks that decrease from proerythroblast to orthochromatic erythroblast stages have CTCF consensus motifs (6%; [Table S4](#SD5){ref-type="supplementary-material"}). Like GATA1, CTCF protein decreased in terminal erythroid differentiation ([Table S1](#SD2){ref-type="supplementary-material"}). CTCF binding sites are classified as those conserved in multiple cell types and those that are cell type specific ([@R99]). Differential footprint analysis in the complete set of ATAC peaks showed no difference in the CTCF motifs as terminal erythroid differentiation progressed (p = 0.85), suggesting that there was no global rearrangement in CTCF occupancy in conserved, non-cell type-specific regions ([Figure S6B](#SD1){ref-type="supplementary-material"}). The CTCF-associated ATAC peaks lost during terminal erythroid differentiation were not subject to differential changes in methylation (Wilcox p = 0.23).

Genomic ChIP-seq (chromatin immunoprecipitation with massively parallel DNA sequencing) data of RUNX1 and PU.1 from HSPC and GATA1, TAL1, and NFE2 mixed populations of cultured human erythroblasts ([@R113], [@R114]; [@R99]) were compared to ATAC peaks in HSPCs and cells from all stages of erythropoiesis ([Figure S6](#SD1){ref-type="supplementary-material"}). GATA1 and TAL1 demonstrated higher co-localization with ATAC peaks from earlier stages of erythropoiesis compared with the later polychromatic and orthochromatic stages of erythropoiesis, which is consistent with the data above. These findings demonstrate that key erythroid transcription factors have dynamic roles in the regulation of programs of gene expression throughout erythropoiesis.

Epigenetic Bookmarking {#S7}
----------------------

Bookmarking is an epigenetic mechanism for transmitting the cellular memory of the pattern of gene expression in a cell throughout mitosis to its daughter cells. This is vital for maintaining the phenotype in a lineage of cells (e.g., erythroid cells divide into erythroid cells and not some other cell type). Thus, the term bookmarking has been extended to apply to changes in the Epigenomics landscape as indicators of cell fate transitions, lineage relations, and cellular dysfunction ([@R100]). We categorized open chromatin regions that exhibited characteristics of bookmarking (i.e., present in a stem or progenitor cell and all subsequent stages). Sites bookmarked in HSPC (375), BFU-E (847), CFU-E (1,460), and proerythroblast (1,647) cells and not present in B and T lymphocytes were studied ([Figures 5A](#F5){ref-type="fig"} and [5B](#F5){ref-type="fig"}; [Table S5](#SD6){ref-type="supplementary-material"}). Bookmarked sites were associated with the increased expression of linked genes and erythroid-linked functional terms, including phenotype traits and associated disorders ([Table S5](#SD6){ref-type="supplementary-material"}). Examples of the levels of linked gene expression with sites bookmarked in BFU-E and CFU-E are shown in [Figures 5C](#F5){ref-type="fig"} and [5D](#F5){ref-type="fig"}.

Characterization of the transcription factor-binding sites under bookmarked ATAC peaks revealed that the overwhelming majority were GATA sites. Remarkably, 55% of bookmarked sites in HSPCs (p = 1e--225) had underlying GATA motifs. In BFU-E, GATA motifs were present in 71% of bookmarked sites (p = 1e--117), in 66% of bookmarked sites in CFU-E (p = 1e--416), and in 52% of bookmarked sites in proerythroblasts (p = 1e--335).

Conservation Analyses of Chromatin Accessibility {#S8}
------------------------------------------------

Evolutionary constraint in regions of noncoding DNA has served as a proxy for functional constraint in the identification of candidate regulatory elements that are also frequently marked by ATAC peaks. Many regulatory elements are rapidly evolving, and in some species, many elements are evolutionarily young and species specific ([@R13]; [@R89]). PhastCons analyses use a hidden Markov model method on aligned genomic sequences to estimate a probability that any nucleotide is conserved and predicts whether a region of DNA contains a functional regulatory element ([@R21]; [@R52]; [@R55]; [@R94]). Maximum 46-way placental mammal PhastCons conservation scores were calculated for erythroid-specific ATAC peaks, hematopoietic ATAC peaks that were not erythroid specific, and a randomized group of ATAC peaks. Moderate conservation was seen for erythroid-specific ATAC peaks (median value 0.63), and strong conservation was seen for shared peaks (0.84) compared to low conservation for random regions (0.42), suggesting that these regions are not only conserved but likely contain functional regulatory elements.

Changes in DNA Methylation throughout Erythropoiesis {#S9}
----------------------------------------------------

We performed genome-wide DNA methylation analyses using enhanced reduced representation bisulfite sequencing (ERRBS) across human erythroid development and differentiation. A pattern of gradual, global demethylation during erythropoiesis was observed ([Figures 6A](#F6){ref-type="fig"} and [6B](#F6){ref-type="fig"}), similar to the data reported in erythropoiesis in mouse fetal liver erythroblasts and human umbilical cord-derived and mobilized erythroid cells ([@R92]; [@R119]; [@R8]). These dynamic changes in demethylation were most prominent along CpG shores (\<2 kb flanking CpG islands, proerythroblast to orthochromatic erythroblast p \< 2.2e--16) and along CpG shelves (\<2 kb flanking outward from a CpG shore, proerythroblast to orthochromatic erythroblast, p \< 2.2e--16) ([Figure S7](#SD1){ref-type="supplementary-material"}), with lower CpG density regions often associated with dynamic changes in methylation. As expected, global methylation at CpG islands including CpG promoters was low, with minimal changes throughout erythropoiesis ([Figure S7](#SD1){ref-type="supplementary-material"}) ([@R35]; [@R121]). While global methylation at CpG promoters was low without significant changes (p = 0.61), there was a decrease in the methylation of non-CpG island promoters throughout erythropoiesis (p \< 2.16e--9; [Figure S7](#SD1){ref-type="supplementary-material"}).

Comparing differential methylation across the stages of erythropoiesis, many regions became demethylated in the transition between BFU-E and CFU-E stages, and a large number of regions gained methylation between CFU-E and proerythroblast stages ([Figure 6C](#F6){ref-type="fig"}).

Correlation of Chromatin Accessibility and DNA Methylation during Erythropoiesis {#S10}
--------------------------------------------------------------------------------

Sites of dynamic patterns of methylation located in regions of open chromatin were sought, as these sites often occur near enhancers and other regulatory elements ([@R62]; [@R107]). The most dramatic changes were observed between the BFU-E and CFU-E stages, with 504 regions (of 24,688 methylated regions) undergoing demethylation ([Figures 6D](#F6){ref-type="fig"} and [6E](#F6){ref-type="fig"}). These regions show significant increases in chromatin opening (p \< 2.2e--16). An example of the dynamic changes in DNA methylation, alterations in chromatin accessibility, and changes in gene expression is shown at the *ZFPM1* gene locus ([Figure 6F](#F6){ref-type="fig"}). Overall integration of gene expression, DNA methylation, and chromatin state dynamics reveal that stage-specific gene regulation during erythropoiesis is a stepwise and hierarchical process involving many *cis*-regulatory elements.

ATAC Peaks Localize to Sites Linked to Erythroid Cell Traits and Erythroid Disease Genes {#S11}
----------------------------------------------------------------------------------------

Genetic variants that modify chromatin accessibility and transcription factor binding are major factors in which genetic variation leads to differences in gene expression ([@R25]; [@R26]; [@R51]; [@R106]; [@R12]; [@R82]; [@R5]; [@R58]). We explored whether SNPs associated with erythroid cell traits were enriched in biologically relevant epigenomic changes. We used the set of noncoding SNPs from the genome-wide association study (GWAS) catalog of the National Human Genome Research Institute (NHGRI) associated with erythroid cell terms (<https://www.genome.gov/gwastudies>) and mapped ATAC peaks and methylation sites by erythroid cell stages. A total of 497 SNPs associated with erythroid cell traits were found in regions of open chromatin ([Table S6](#SD7){ref-type="supplementary-material"}).

One hundred seventy-three SNPs found in ATAC peaks associated with erythroid cell traits were within 1 kb of a gene promoter, while 324 were not. Examples of erythroid trait-associated SNPs bookmarked in CFU-E cells that were also erythroid specific are shown in [Figures 7A](#F7){ref-type="fig"} and [7B](#F7){ref-type="fig"}. Many of these SNP-associated ATAC peaks were bookmarked, as noted above, especially those found in HSPCs, CFU-E, and proerythroblasts ([Figure 7C](#F7){ref-type="fig"}). Of the SNP-associated ATAC peaks, 103 were erythroid specific ([Table S4](#SD5){ref-type="supplementary-material"}); 19 differentially methylated regions were associated with SNP-associated ATAC peaks.

Several bookmarked regions of open chromatin contained SNPs linked to GWAS-associated erythroid cell phenotypic traits, 11 in HSPCs, 6 in BFU-E cells, 38 in CFU-E cells, and 29 in proerythroblast cells ([Table S4](#SD5){ref-type="supplementary-material"}). Two of the GWAS-associated sites in HSPCs were at or near sites encoding critical regulatory genes ([Figures 5A](#F5){ref-type="fig"} and [5B](#F5){ref-type="fig"}). One was located in the HBS1L-MYB intergenic region of chromosome 6 and the other in an intronic site in the *SOX6* gene. The HBS1L-MYB intergenic SNP, rs9494142, and other SNPs in the region have been associated with hemoglobin, hematocrit, hemoglobin F, hemoglobin A2, mean cell volume, and mean corpuscular hemoglobin concentration (MCHC). This bookmarked ATAC peak SNP is associated with a GATA-containing enhancer linked to the *MYB* gene via chromosome conformation capture, influencing its expression ([@R97]). The intronic *SOX6* SNP, rs17462448, has been associated with MCHC and red blood cell distribution width. Notable GWAS-associated sites bookmarked in BFU-Es include rs35152987 at the β-globin gene locus, rs737092 at the *RBM38* gene locus, and rs2703485 at the *KIT* locus (not shown).

We compared regions of chromatin accessibility in a well-characterized, comprehensive panel of genes linked to inherited anemia (Mayo Clinic ID: NGHHA, with *STOM* and *UGT1A1* genes removed and *HBA1*, *HBA2*, and *KCNN4* genes added). All but 4 of the 40 genes had regions of chromatin accessibility in ≥1 stages of erythroid development or differentiation (data not shown). Of note, 76 erythroid-specific regions of chromatin accessibility were observed in 24 of these genes (p \< 0.0001; c.f., randomized genomic intervals).

DISCUSSION {#S12}
==========

Human erythropoiesis is one of the best-characterized models of cell development and differentiation serving as a paradigm for understanding mechanisms of development and differentiation in other cell types ([@R69]; [@R105]; [@R113], [@R114]). Epigenetic studies have shown that critical regulatory elements appear to be gained and lost during hematopoiesis ([@R113]; [@R59]; [@R45]). Our erythroid cell data confirm and expand these observations, with sites of chromatin accessibility gained and lost throughout erythropoiesis. Our data also reveal that chromatin states differ by specific erythroid stages, with marked transitions between some stages, refining results compared to previous studies of mixed populations of erythroid cells ([@R25]), indicating that cell stage-specific activation of gene loci during erythropoiesis is a stepwise and hierarchical process that involves many *cis*-regulatory elements ([@R15]).

Tissues adopt varying strategies to establish downstream gene regulatory networks. For instance, chromatin architecture in intestinal stem cells exhibited features of active enhancers, including regions of chromatin accessibility, that were then broadly conserved in differentiating intestinal progenitor cells at or near genes exclusively expressed in intestinal cells ([@R54]). In contrast, in a murine hematopoiesis model, active regulatory elements were dynamically regulated, with stem and progenitor cell populations showing very few regions of chromatin marking active elements, which were then acquired de novo during lineage commitment and differentiation ([@R71]). A limited number of sites of chromatin accessibility identified in HSPCs were identified in cells committed to the erythroid lineage. This is similar to B lymphocytes, in which the majority of the active regulatory elements in differentiated B lymphocytes were not marked in HSPCs ([@R74]; [@R24]). These observations demonstrate that a dynamic program of chromatin accessibility is shaped during lineage commitment and differentiation in hematopoiesis, including erythropoiesis, and that this program is independent of early chromatin priming.

DHS mapping and ATAC-seq across many cell types have allowed the construction of transcription factor regulatory circuits and demonstrated various degrees of similarity between cell types ([@R75]; [@R93]). Our data demonstrate that genome-wide patterns of chromatin accessibility are unique to cells in the terminal stages of erythroid differentiation, indicating that a highly specialized regulatory DNA landscape is present, likely evolved to direct a program conferring specialized functions to the mature erythrocyte. In parallel, they also reveal that patterns of chromatin accessibility in erythropoiesis are the most divergent among hematopoietic cell types, again likely attributable to erythroid cell function.

It will be interesting to compare conservation of the human erythroid epigenetic landscape to other species, allowing us to highlight shared pathways of erythroid cell function ([@R51]). Comparison of human and murine regulatory elements in proerythroblasts suggest that evolutionary divergence drives the changes in gene expression ([@R106]). Human erythroid regulatory elements appear to be under weak evolutionary constraint, especially when compared to placental mammals and nonplacental vertebrates, and many are species specific and evolutionarily young ([@R101]). This is likely because mammalian erythrocytes are one of the most highly specialized cell types known. The mature erythrocyte has evolved to a cell that lacks a nucleus with unique membrane function and excess membrane surface area relative to cell volume that enable efficient oxygen delivery to meet the increased oxygen demand of evolving homeotherms ([@R91]).

A limitation of our study is the use of cell culture to obtain adequate numbers of primary erythroid cells, with the results likely suffering from artifacts of culture conditions per se. A goal is to perform epigenomic and transcriptomic studies on uncultured primary human erythroid cells isolated directly from the bone marrow of normal individuals at steady state.

Regions of chromatin accessibility, identified by DHS sites and/or ATAC peaks, often map to enhancers and other regulatory elements. The DNA sequence under DHS sites and ATAC peaks yields a collection of highly enriched transcription factor-binding motifs, as DHS sites and ATAC peaks define a much more limited DNA region compared to the broad regions of histone modifications ([@R96]; [@R104]). DHS mapping and ATAC-seq have also revealed that chromatin accessibility patterns may exhibit individual- and allele-specific chromatin signatures ([@R12]; [@R82]; [@R115]). The mapping of DHS sites and ATAC peaks to genetic loci associated with various genetic traits by genome-wide association studies is a powerful technique that has yielded novel insights into quantitative trait variation and genetic disease ([@R58]; [@R1]; [@R6]; [@R26]; [@R31]; [@R56]; [@R100]). We found large numbers of epigenomic changes at SNPs linked to GWAS-associated erythroid cell traits near genes encoding proteins that are critical for erythroid cell development and function ([Table S2](#SD3){ref-type="supplementary-material"}).

These previously undescribed stage-specific patterns of chromatin accessibility linked to genetic loci associated with erythroid traits and inherited erythrocyte disorders will allow the interrogation of changes in the epigenome and associated gene expression changes and target them to specific erythroid stages. For instance, in the early stages of terminal erythroid differentiation, iron accumulates in ferritin ([@R80]). As differentiation proceeds into the basophilic and orthochromatic erythroblast stages, large amounts of iron are imported through ferritin in parallel with high rates of iron transfer to the mitochondria. The programs of gene and protein expression required for these processes can now be better understood in a stage-specific manner.

Defining these regulatory regions in erythroid cells will also be useful in the genetic diagnosis of patients with hematologic disease. In some recessively inherited diseases, deleterious coding region mutations are identified in causative genes only on one allele, with the causative mutation in *trans* not identified. A subset of patients with recessively inherited pyruvate kinase deficiency has disease-associated mutations on one or neither *PKLR* gene alleles after mutation screening of the promoter and coding exons ([@R11]). In recessively inherited congenital dyserythropoietic anemia type II (CDAII), a subset of patients who exhibit all of the phenotypic and laboratory characteristics of CDAII, a disease-associated *SEC23B* mutation has been identified on only one allele ([@R47]; [@R87]). Both genes have candidate ATAC peaks in the genomic vicinity, making them candidate regions for disease-associated mutations. The data and tools provided here should serve as helpful resources for the study of normal and perturbed human erythropoiesis.

STAR★METHODS {#S13}
============

LEAD CONTACT AND MATERIALS AVAILABILITY {#S14}
---------------------------------------

For further information and requests for resources should be directed to and will be fulfilled by Patrick G. Gallagher (<patrick.gallagher@yale.edu>).

Materials Availability Statement: This study did not generate new unique reagents.

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S15}
--------------------------------------

### Human Subjects {#S16}

Human cord blood was obtained from the National Cord Blood Program, New York Blood Center. Studies were conducted with Institutional Review Board approval of the New York Blood Center. All umbilical cord samples were completely de-identified; thus sex, race, and ethnic background of the donors were not provided.

### Model {#S17}

Erythroid cell culture of human umbilical cord-derived CD34+ hematopoietic stem and progenitor cells (HSPCs) and fluorescence-activated cell sorting to isolate discrete, highly purified populations of cells at differing stages of erythroid development and differentiation were performed as described below ([@R4]; [@R65]; [@R20]).

#### Isolation and culture {#S18}

CD34+ cells were purified from umbilical cord blood by positive selection using the CD34 MicroBead Kit UltraPure (Miltenyi Biotec), according to the manufacturer's instructions. Purity of isolated CD34+ cells was 90%--98%. To enrich for erythroid progenitor cells, CD34+ cells were cultured in expansion medium with StemSpan SFEM (StemCell technologies) as base medium for 4 days supplemented with 10% FBS (GE Healthcare), 10 ng/mL IL-3 (StemCell technologies), 50ng/mL stem cell factor (StemCell Technologies), 1IU/mL erythropoietin (ThermoFisher Scientific) and 0.06mM α-thioglycerol (Sigma) starting at a cell concentration of 10^5^/mL ([@R46]). To promote erythroid differentiation, cells were then cultured in a series of 3 phases.^2^ Composition of the base culture medium was Iscove's Modified Dulbecco's Medium, 2% human peripheral blood plasma (StemCell Technologies), 3% human AB serum (Atlanta Biologicals), 3 IU/mL heparin (StemCell Technologies), and 10 μg/mL insulin (Sigma). In the first phase (day 0-6), CD34+ cells at a concentration of 10^5^/mL were cultured in the presence of 1ng/mL IL-3, 10ng/mL stem cell factor, 3IU/mL erythropoietin and 200μg/mL Holo-human transferrin (Sigma). In the second phase (day 7-11), IL-3 was omitted and erythropoietin was reduced to 1IU/mL. In the third phase, stem cell factor was removed, holo-human transferrin was increased to 1mg/mL and cell concentration was adjusted to 10^6^/mL on day 11 and to 5 × 10^6^/mL on day 15, respectively. All cell cultures were incubated at 37°C in the presence of 5% CO~2~.

#### Fluorescence-activated cell sorting {#S19}

Cells cultured in expansion medium for 4 days were used for sorting of BFU-E and CFU-E cells, separately. Harvested cells were washed with cold PBS/0.5% BSA and suspended in PBS/0.5% BSA at a concentration of 20 million/mL, blocked with 4% human AB serum for 10 min, then incubated with PE-conjugated mouse anti-human CD34 (BD Biosciences), FITC-conjugated mouse anti-human CD36 (BD Biosciences), APC-conjugated mouse anti-human glycophorin A (BD Biosciences) and PE-Cy7-conjugated mouse anti-human IL3-R (ThermoFisher Scientific) at 4°C for 30 min in the dark. Cells were washed twice with PBS/0.5% BSA, re-suspended in PBS/0.5% BSA at a concentration of 15 million/mL and stained with cell viability dye 7-AAD on ice for 10 min in the dark. Cell debris and dead cells were excluded from analysis based on scatter signal and 7-AAD fluorescence. BFU-E colony forming IL3R-GPA-CD34+CD36- cells and CFU-E colony forming IL3R-GPA-CD34-CD36+ cells, respectively, were collected ([Figure S1](#SD1){ref-type="supplementary-material"}).

To isolate erythroblasts representing stages of terminal erythroid differentiation, in the third phase of culture, proerythroblast, early basophilic erythroblasts and late basophilic erythroblasts were isolated after 7 days of culture and polychromatic and orthochromatic erythroblasts were isolated after 13-14 days of culture. Cells were harvested and prepared as described above, then stained with PE-conjugated mouse anti-human GPA (BD Biosciences), FITC-conjugated mouse anti-human band 3 (New York Blood Center) and APC-conjugated mouse anti-human a4-integrin (Miltenyi Biotec). Cell debris and dead cells were excluded from analysis based on scatter signal and 7-AAD fluorescence. From GPA+ cells, proerythroblasts, early basophilic erythroblasts, late basophilic erythroblasts, polychromatic erythroblasts, and orthochromatic erythroblasts were gated and collected based on their expression level of Band 3 and μ4-integrin ([Figure S5](#SD1){ref-type="supplementary-material"}). Sorting was performed on a MOFLO high-speed cell sorter (Beckman-Coulter).

#### Validation: Sorting, colony assay and morphology {#S20}

Purities of all sorted populations were examined by analytic flow cytometry analysis using the antibodies and sorting schemes described above. Colony assays were performed to validate the sorted progenitor populations (BFU-E and CFU-E) functionally. Two semi-solid media, MethoCult H4434 classic media and MethoCult H4330 EPO-alone media (Stem Cell Technologies), were used for colony assay to validate the colony forming potential of sorted erythroid progenitor cells, according the manufacturer's instruction. Collected IL3R-GPA-CD34+CD36- cells and IL3R-GPA-CD34-CD36+ cells were diluted to a density of 200 cells/ml of semi-solid medium, cultured at 37°C in the presence of 5% CO~2~. CFU-E and BFU-E colonies were defined according to the criteria described by [@R28]. CFU-E colonies in EPO-alone media were counted on day 7 of culture and BFU-E colonies in classic media were counted on day14 of culture.

Cytospin preparations were prepared to validate the sorted erythroblasts morphologically. 10^5^ sorted erythroblasts from each stage were resuspended in 200μl PBS for cytospin preparation on coated slides using a ThermoScientific Shandon4 Cytospin. Slides were stained with May-Grunwald (Sigma) solution for 5 min, rinsed in 40mM Tris buffer (pH 7.2) for 90 s, and subsequently stained with Giemsa solution (Sigma) for 15 min. After staining, slides were rinsed in double distilled water and dried at room temperature. Slides were imaged using a Leica DM2000 inverted microscope with images obtained at 100 × magnification.

METHOD DETAILS {#S21}
--------------

### RNA Sequencing {#S22}

*BFU-E* and *CFU-E*. RNA was prepared from HSPCs and BFU-E and CFU-E primary human erythroid progenitor cells for RNA-seq analyses using an RNeasy mini kit (QIAGEN) per manufacturer instructions on three biologic replicates from unrelated donors ([@R98]). RNA samples were treated with RNase-free DNase I (Takara, Otsu, Japan), quantified using a NanoDrop1000 (Thermo-Fisher, Waltham, MA) and assessed with an Agilent2100 Bioanalyzer (Agilent, Santa Clara, CA). The RNA integrity number of each sample was \>9. DNA libraries were prepared according to manufacturer's instructions (Illumina, San Diego, CA). Each library was sequenced on the Illumina HiSeq2000 platform using a 50-bp single-end, non-strand specific sequencing strategy ([@R4]). Deep sequencing was performed on polyA+ mRNA from the 3 biological replicates of HSPCs and each erythroid stage. RNA-seq data for human primary erythroblasts representing erythroblast through orthochromatic erythroblast stages were obtained from NCBI GEO: GSE53983. Primary and downloaded data were analyzed and subjected to quality control analyses using the FastQC and QoRTS packages ([@R40]). Sequence reads were mapped to the human genome version hg19 using TopHat version 2.0.13 ([@R53]). Reads were counted for each gene using featureCounts ([@R68]).

Gene expression was analyzed using the EdgeR package ([@R85]). Only genes with 3 or more samples in the dataset with \>1 count per million reads were analyzed. The Trimmed Mean of M values (TMM) method was used for normalization ([@R84]). Principal component analysis (PCA) was performed on log transformed counts per million values for expressed genes. Differentially expressed genes in adjacent stages, HSPC to ProE, and ProE to Ortho were identified using the EdgeR exact-Test. The set of 341 highly expressed erythroid genes was defined by having orthochromatic erythroblast RPKM \> 64 and \>32-fold increase compared to HSPC. Clustering of differentially expressed genes with similar expression patterns was performed using k-means with 25 clusters, and clusters with visually similar patterns were merged together. Gene ontology analysis was performed using the goseq package ([@R116]).

ATAC sequencing {#S23}
---------------

ATAC sequencing was performed using 50,000 primary erythroid cells per reaction ([@R16]; [@R25]) from two biological replicates of HSPCs and each erythroid stage from unrelated donors. After washing once with cold PBS, cells were lysed using cold lysis buffer (10mM TrisHCl, pH 7.4, 10mM NaCl, 3mM MgCl~2~ and 0.1% IGEPAL CA-630). Nuclei were collected by centrifugation, with the pellet resuspended in 50ul transposase reaction mix (25 μL 2 × TD buffer, 2.5 mL transposase (Illumina Nextera FC121-1030 TDE1 and TD Buffer) and 22.5 μL nuclease-free water). The transposition reaction was carried out for 30 min at 37°C in a thermocycler. Following transposition, samples were purified using a MinElute kit (QIAGEN) following manufacturer's instructions and eluted in 24 μL.

Library assembly was done by PCR in a reaction mix containing 25uL HiFi 2x mix (HiFi HotStart ReadyMix PCR Kit (Kapa), 24uL of tagmented DNA and 1uL primer mix (12.5uM each of AD1 and AD2 primer mix) ([@R17]). PCR conditions were 72°C for 5 min (adaptor extension), 98°C for 45 s (denaturation) and 5 cycles (98°C for 15 s, 63°C for 30 s, 72°C for 30 s), ending with 72°C for 1 min. The reaction was cleaned with the MinElute kit (QIAGEN) and eluted in 50 μL. Size selection was done with an EZNA size select kit (Omega) for isolation of 150-700bp fragments following manufacturer's instructions. Q-PCR library amplification test was done to determine the additional number of cycles needed for the sequencing library in a mixture containing 5uL size-selected DNA, 1uL SYBR, 1uL G3306/3307 primers, 3uL H2O, and 10uL 2x KAPA HiFi mix for 20 cycles (95°C for 45 s, 20 × (95°C for 15 s, 63°C for 30 s and 72°C for 30 s). Primer sequences were: G3306 5′-AATGATACGGCGACCACCGA-3′ and G3307 5′-CAAGCAGAAGACGGCATACGA-3′. PCR library amplification was done in a reaction of 5uL size-selected DNA, 1uL G3308/3309 primers, 19uL H~2~O and 25uL 2x KAPA HiFi mix with PCR amplification for Y number of cycles determined by Q-PCR: 98°C for 45 s, Y x (98°C for 15 s, 63°C for 30 s, and 72°C for 30 s), ending with 72°C for 1 min. Primer sequences were: G3308 5′- AATGATACGGCGACCACCGAGATCTACA\*C-3′ and G3309 5′- CAAGCAGAAGACGGCATACGAGA\*T-3′ with \*phosphorothioate bond. PCR amplified sequencing libraries were cleaned with 0.9 volumes of AMPure Beads (Beckman Coulter). Quality of the library was determined by analysis on an Agilent Bioanalyzer.

For each sample, 47-85 million 76 base, single end sequence reads were obtained on an Illumina HiSeq 2500 sequencer ([Table S2](#SD3){ref-type="supplementary-material"}). Sequenced reads were trimmed using Trimmomatic version 0.32 and mapped to the human genome (hg19 GRCh37) using the Burrows-Wheeler Aligner version 0.7.9a mem alignment program ([@R14]; [@R63]). Reads with poor mapping quality or that mapped to the ENCODE project blacklist of repetitive regions and mitochondrial regions were removed ([@R18]). Coverage files for genomic visualization in IGV were generated using bedtools after extending reads by 100 base and normalized per million reads ([@R83]). MACS2 program version 2.1.1.20160309 was used to identify peaks using parameters nomodel shift −100 extsize 200 with a q value of \< 0.05 ([@R120]). To pass quality control, sequencing datasets were required to have PHRED score \>35 assessed using FASTQC, \>10 million reads, \>10,000 called peaks, and good peak quality in visual inspection of read coverage profiles. Other ATAC datasets downloaded from GEO were processed and assessed in the same way, using only the first read even if paired end reads were available. Read counts for open chromatin regions in all samples were obtained using the DiffBind version 2.4.8 package with DESEQ2 normalization using all aligned reads (parameter bFullLibrarySize = TRUE) ([@R86]). Statistically significant differentially accessible regions were identified by DiffBind using the DESEQ2 method with default parameters ([@R70]). ATAC peaks/regions were linked to genes using the single nearest transcription start site (TSS) for RefSeq transcripts \< 50000bp away utilizing the GenomicRanges package ([@R60]). ATAC peaks/regions \< 1000bp from the nearest TSS were designated as promoters.

Erythroid specific peaks with 16-fold change were identified using DESeq2 version_1.16.1 comparing the erythroid read counts to hematopoietic progenitor, dendritic, B and T lymphocyte cell counts, in the merged set of regions in all datasets ([@R70]).

Overrepresented motifs in ATAC peak sets were identified using the HOMER (Hypergeometric Optimization of Motif EnRichment) suite of tools for Motif Discovery ([@R44]). Peak regions were intersected with the MACS2 summit positions, and overrepresented motifs in the 200 base pair region flanking the summits within the repeat masked Hg19 genome. Differential footprints between proerythroblasts and orthochromatic erythroblasts were identified using the HINT algorithm utilizing the mapped reads and peak calls from one replicate of each cell type ([@R66]).

Functional analysis of ATAC peak sets was performed using the GREAT algorithm (Genomic Regions Enrichment of Annotations Tool) ([@R73]). Default parameters were used (Basal plus extension, 5kb upstream 1kb downstream plus distal up to 1MB, utilizing curated regulatory domains), and mouse phenotype category enriched terms are reported.

ATAC peak localization was compared to downloaded ChIP-seq datasets. ChIP-seq datasets were mapped as above, and peaks were called using MACS2 using default parameters for transcription factors, using-broad-broad-cutoff 0.01-qvalue 0.01-nomodel-extsize 147 for H3K27Ac, and using-broad-broad-cutoff 0.001-qvalue0.001-nomodel-extsize 147 for H3K4me1. Sicer was used to identify enriched regions in H3K27me3 that were further filtered to keep regions with ≥ 3-fold enrichment. Overlap of regions was assessed using bedtools Jaccard and with testing of overlap compared to multiple shuffles of randomized regions.

Conservation analysis of ATAC regions used 46 way placental mammal PhastCons scores downloaded from the UCSC database (<http://hgdownload.cse.ucsc.edu/goldenpath/hg19/phastCons46way/placentalMammals/>) that gives a conservation score of each base in the human genome compared to the alignment of 45 vertebrate genomes (six fish, one amphibian, one reptile, two avian, three non-placental mammal and thirty two placental mammals) ([@R95]; [@R94]). The maximum phast-Cons score for each erythroid specific genomic interval to be tested was obtained, and the set of maximum scores was compared to the maximum scores of randomized intervals or non-erythroid specific ATAC regions. The randomized intervals were obtained using the Bedtools shuffle command on erythroid-specific regions. Promoter and exonic regions were removed from all three region sets prior to conservation analysis, since changes in promoter and exon composition could skew the conservation analysis.

### Methylation assays {#S24}

Genome-wide DNA methylation profiles were created using an enhanced reduced representation bisulfite-based sequencing (ERRBS) technique ([@R2]; [@R33]). Three biological replicates of HSPCs and each erythroid stage were utilized from unrelated donors. Genomic DNA was extracted from stage-specific erythroid progenitor or erythroblast cells using the PureGene Kit (QIAGEN) per manufacturer's instructions. 100ng DNA was digested with 200U Mspl (New England Biolabs) in a 100 mL reaction at 37°C for 18 h, then extracted with phenol-chloroform followed by ethanol precipitation and resuspended in 30 μL 10mM TrisCl pH 8.0. End repair of extracted DNA was performed in 100 μL of T4 DNA buffer, 15U of T4 DNA polymerase, 5U Klenow DNA polymerase, 50U T4 Polynucleotide Kinase and 4 μL premixed nucleotide triphosphates (All reagents from New England Biolabs) with incubation at 20°C for 30 min. DNA was extracted using QIAquick PCR columns per manufacturer's instructions (QIAGEN). Adenylation was performed in 32 μL of DNA solution in elution buffer, 15U Klenow fragment and 10 μL of dATP at 1mM in Klenow buffer added (All reagents, New England Biolabs) for total reaction volume of 50 μl, with incubation at 37°C for 30 min. DNA was purified using MinElute PCR columns per manufacturer's instructions (QIAGEN) into 10 μL of elution buffer. Adaptor ligation was performed in a total volume of 50 μL, 2000U T4 DNA ligase (New England Biolabs) and the Methylated Illumina adapters at a final concentration of 1.2mM with incubation for 16 h at 16°C. Products were isolated using PCR MinElute as previously described into 10 mL of elution buffer. For size selection, library fragment lengths of 150-250bp and 250-400bp were gel selected from a 1.5% agarose gel then isolated using QIAquick gel extraction kit (QIAGEN) per manufacturer's instructions into 40 μL of elution buffer. Bisulfite conversion was performed using an EZ DNA methylation kit (Zymo Research) as per manufacturer's instructions with the following modifications; after addition of CT conversion agent, the incubation was done on a thermocycler for 55 cycles of 95°C for 30 s, 50°C for 15 min, followed by elution of products into 40 μL of nuclease free water. PCR amplification was performed in a reaction volume of 200 mμL containing 2 mμL FastStart High Fidelity DNA polymerase (Roche), 0.5 mM each of the PE1.0 and PE2.0 Illumina PCR primers and 0.25mM of each nucleotide triphosphate using buffer 2. The reaction was split into four 50 mμL tubes and with thermal cycling as follows: 94°C for 5 min, 18 cycles of 20 s at 94°C, 30 s at 65°C, 1 min at 72°C, followed by 3 min at 72°C. PCR products from the combined 4 tubes were isolated using AMPure XP beads (Beckman Coulter) per manufacturer's instructions. Libraries underwent quality control using Quant-IT dsDNA High Sensitivity Assay Kits on a Qubit 1.0 fluorometer.

Amplified libraries were sequenced using 50bp single-end read runs on an Illumina HiSeq2000 sequencer. Image capture, analysis, and base calling were performed using CASAVA 1.8 (Illumina). Reads were trimmed using Trim Galore v0.4.0 in rrbs mode (<https://www.bioinformatics.babraham.ac.uk/projects/trim_galore/>), and were then mapped to the hg19 genome using Bismark_v0.14.3 ([@R57]). Differential methylation was identified using methylKit v1.2.4 ([@R3]). Regions with less than 10 read coverage or greater than 99.9th percentile of coverage were discarded. Coverage values between samples were normalized using a scaling factor derived from differences between median of coverage distributions. Only CpG's with 2 or more covered samples per group were analyzed. Differential methylation in CpG or different classes of genomic regions was identified by comparing two cell types using the MethylKit calculateDiffMeth function with a q-value cutoff of 0.01 requiring 25% change in methylation.

### Genome-Wide Association Study Information {#S25}

The NHGRI catalog of GWAS SNPs was downloaded from <https://www.ebi.ac.uk/gwas/docs/file-downloads> ([@R72]). Erythroid terms related to anemia, corpuscular, erythrocyte, F-cell, ferritin, HBA2 levels, hematocrit, hematological phenotypes, hemochromatosis, hemoglobin, iron, red blood, red cell, transferrin saturation were used to select 3645 Erythroid trait SNP's. PLINK 1.9 was used to identify SNPs within one megabase in high linkage, R^2^ \> 0.8 in the European samples of the 1000 genomes database ([@R19]). The combined set of 6844 GWAS plus linked SNPs was used for further analysis.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S26}
---------------------------------------

Statistical analysis was conducted using R version 3.4.1 (<http://www.R-project.org/>). The Wilcox test was used except as otherwise noted. Significance of overlap of genomic intervals was assessed by comparing the number of overlaps with the number of overlaps from multiple shuffles of randomized genomic regions. HOMER motif enrichment uses a hypergeometric distribution to calculate p values.

DATA AND CODE AVAILABILITY {#S27}
--------------------------

The raw data files have been submitted to the Gene Expression Omnibus (GEO, <https://www.ncbi.nlm.nih.gov/geo/>) and the VISION databases (<http://www.bx.psu.edu/~giardine/vision/>). The accession number for the RNA-seq, ATAC-seq and methylation analyses reported in this paper is GEO: GSE128269.
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![Regions of Open Chromatin Identified during Erythropoiesis\
(A) ATAC peaks at the β-globin-like gene locus.\
(B)ATAC peaks at the *BCL11A* gene locus.\
(C)Bar chart representation of differential changes in open chromatin as identified by ATAC peaks by stages of erythropoiesis, with sites of acquired ATAC peaks shown in red and sites of lost ATAC peaks shown in blue.\
(D)Distribution of ATAC peaks in human erythroid cells at differing stages of erythroid development and differentiation. The human genome was portioned into seven bins relative to RefSeq genes. The percentage of the human genome represented by each bin was color coded, and the distribution of ATAC peaks placed in each bin was graphed on the color-coded bar. The Genome Bar is a graphical representation of the relative proportions of the different location categories in the entire human genome.\
TES, transcriptional end site; TSS, transcriptional start site.](nihms-1539602-f0002){#F1}

![Erythroid Cells Exhibit Unique Stage- and Cell Type-Specific Patterns of Nonpromoter Chromatin Accessibility\
(A)Chromatin accessibility at the *HK1* locus demonstrating erythroid-specific (red) ATAC peaks.\
(B)Read count correlation of ATAC peaks in erythroid and nonerythroid hematopoietic cells.\
(C)Heatmap of differential ATAC regions between erythroid cells and other hematopoietic cell types. The regions at the top far right, representing terminal erythroid differentiation, show high accessibility in erythroid cells, and the regions at bottom have low accessibility in erythroid cells compared to other hematopoietic cell types.\
(D)GREAT (genomic regions enrichment of annotations tool) analysis of erythroid-specific regions of chromatin accessibility revealed significantly enriched terms for erythroid-related traits. The log10 binomial p value of each category is shown at right.\
(E)Principal-component analysis of patterns of chromatin accessibility in erythroid, nonerythroid hematopoietic, and nonhematopoietic cells.\
(F)Hierarchical cluster analysis shows terminally differentiating erythroid cells clustering separately from all of the other hematopoietic and nonhematopoietic cells (orange box, lower left corner).](nihms-1539602-f0003){#F2}

![Chromatin Accessibility and Gene Expression\
Levels of gene expression determined by RNA-seq were correlated with the location of ATAC peaks in linked gene promoters, linked nonpromoter regions, both, or neither.\
(A)Patterns of gene expression associated with ATAC peak presence or absence as described are shown in CFU-E, early basophilic erythroblasts, and orthochromatic erythroblasts.\
(B)Levels of gene expression and gain or loss of ATAC peaks. In general, as gene loci acquired ATAC peaks, levels of gene expression increased. Shown here in the transitions from HSPC to BFU-E, BFU-E to CFU-E, and CFU-E to proerythroblast (ProE), the gene expression of linked genes that lost ATAC peaks (blue) is significantly lower than the expression of linked genes that gained ATAC peaks (red).\
(C)*SLC2A1* gene locus. Patterns of chromatin accessibility denoted by ATAC peaks (blue) are apparent in erythroid differentiation before the onset of detectable gene expression identified by RNA-seq (red).](nihms-1539602-f0004){#F3}

![Transcription Factor Activity Changes across Erythropoiesis\
(A)The top regulatory protein-binding sites identified by the HOMER algorithm searching ±50 bp from summits of differential increasing stage to stage ATAC peaks. The top four motifs ranked by p value are shown for erythroid cell type transitions.\
(B)Gene expression of critical erythroid transcription factors are shown for each stage of erythropoiesis. Transcriptome data are from [@R4] and the present article.\
(C)Protein expression of critical erythroid transcription factors are shown for each stage of erythropoiesis. Protein data are from [@R34].](nihms-1539602-f0005){#F4}

![Chromatin Accessibility Bookmarking and Gene Expression\
Sites of chromatin accessibility identified in HSPC, BFU-E, CFU-E, or ProE cells, respectively, and all of the other subsequent erythroid stages were defined as exhibiting bookmarking.\
(A and B) Examples of bookmarked regions of open chromatin in HSPCs in the *HBS1L/MYB* intergenic region (A) and the SOX6 locus (B) are shown. Both of these bookmarked sites contain SNPs (associated dbSNP identifiers) linked to genome-wide association study (GWAS)-associated erythroid cell phenotypic traits.\
(C and D) Comparison of gene expression of bookmarked-linked genes (red) compared to control, non-bookmarked genes (blue) is shown in BFU-E (C) and in CFU-E (D) cells.](nihms-1539602-f0006){#F5}

![Dynamic Changes in Methylation across Erythropoiesis\
(A)Boxplots of the percentage of methylation of 5-kb genomic windows show a gradual decrease in methylation.\
(B)Dynamic changes in methylation in the regions of the *RBM38* gene locus. Changes from DNA methylation (red, height indicates number of methylated reads) to demethylation (blue, height indicates number of unmethylated reads) are observed.\
(C)Numbers of differentially methylated regions are shown in 5-kb tiled regions across the genome. Red indicates regions of gained methylation and blue indicates regions of lost methylation.\
(D)Numbers of differentially methylated regions located in open chromatin.\
(E)Heatmap display of methylation levels (%) in open chromatin regions with dynamic methylation.\
(F)Dynamic changes in DNA methylation, alterations in chromatin configuration, and pattern of gene expression at the *ZFPM1* gene locus.](nihms-1539602-f0007){#F6}

![Sites of Chromatin Accessibility Containing Genome-wide Association Study-Linked SNPs Linked to Erythroid Cell Traits\
ATAC peaks were mapped onto the GWAS catalog of the National Human Genome Research Institute associated with erythroid cell terms.\
(A and B) Examples of erythroid-specific, erythroid trait-associated SNPs in ATAC peaks bookmarked in CFU-E cells are shown at the *RCL1* gene locus (A, two SNPs) and the *PIEZO1* gene locus (B, one SNP).\
(C) The x axis represents the 497 SNPs associated with erythroid cell traits ordered from right to left. The top of the heatmap (red) shows each ATAC peak that contains a GWAS erythroid-associated SNP by erythroid stage. The bottom half of the heatmap (blue) shows the trait associated with each ATAC peak-containing GWAS SNP. Many SNPs were bookmarked, and most were associated with more than one erythroid cell trait.](nihms-1539602-f0008){#F7}

###### 

KEY RESOURCES TABLE

  REAGENT or RESOURCE                                              SOURCE                    IDENTIFIER
  ---------------------------------------------------------------- ------------------------- ------------------------------------------------------------------------------------------------------------------------------
  Antibodies                                                                                 
  PE-Cy7-conjugated mouse anti-human IL3-R                         Thermofisher Scientific   Cat\# 25-1239-42; RRID: AB_1257136
  APC-conjugated mouse anti-human Glycophorin A                    BD Biosciences            Cat\# 551336; RRID: AB_398499
  PE-conjugated mouse anti-human CD34                              BD Biosciences            Cat\# 555822; RRID: AB_396151
  FITC-conjugated mouse anti-human CD36                            BD Biosciences            Cat\# 555454; RRID: AB_2291112
  PE-conjugated mouse anti-human GPA                               BD Biosciences            Cat\# 555570; RRID: AB_395949
  APC-conjugated mouse anti-human α4-integrin                      Miltenyi Biotec           Cat\# 130-093-281; RRID: AB_1036218
  FITC-conjugated mouse anti-human band 3                          NY Blood Center           <mnarla@nybc.org>
  7-AAD                                                            BD Biosciences            Cat\# 559925
  Biological Samples                                                                         
  Human cord blood                                                 New York Blood Center     <https://nybloodcenter.org/products-and-services/blood-products/research-products/>
  Chemicals, Peptides, and Recombinant Proteins                                              
  SFEM                                                             StemCell Technologies     Cat\# 09650
  FBS                                                              GE Healthcare             Cat\# S40110H
  IL-3                                                             StemCell Technologies     Cat\# 78040
  SCF                                                              StemCell Technologies     Cat\# 78062
  EPO                                                              ThermoFisher Scientific   Cat\# PHC2054
  α-thioglycerol                                                   Sigma-Aldrich             Cat\# M6145-25ML
  human peripheral blood plasma                                    StemCell Technologies     Cat\# 70039.5
  human type AB serum                                              Atlanta Biologicals       Cat\# S40110H
  heparin                                                          StemCell technologies     Cat\# 07980
  insulin                                                          Sigma-Aldrich             Cat\# I9278
  Holo-human transferrin                                           Sigma-Aldrich             Cat\# T4132-1G
  BSA                                                              Sigma-Aldrich             Cat\# A7030-100G
  May-Grunwald stain                                               Sigma-Aldrich             Cat\# MG128-4L
  Giemsa stain                                                     Sigma-Aldrich             Cat\# GS1L-1L
  MethoCult H4434 Classic                                          StemCell Technologies     Cat\# 04434
  MethoCult H4330                                                  StemCell Technologies     Cat\# 04330
  MspI restriction enzyme                                          New England Biolabs       Cat\# R0106T
  T4 DNA polymerase                                                New England Biolabs       Cat\# M0203S
  T4 DNA ligase reaction buffer                                    New England Biolabs       Cat\# B0202S
  DNA polymerase I, Large (Klenow) fragment                        New England Biolabs       Cat\# M0210S
  T4 polynucleotide kinase                                         New England Biolabs       Cat\# M0201S
  Deoxynucleotide (dNTP) solution set                              New England Biolabs       Cat\# N0446S
  dATP solution                                                    New England Biolabs       Cat\# N0440S
  NE Buffer 2                                                      New England Biolabs       Cat\# B7002S
  T4 DNA ligase                                                    New England Biolabs       Cat\# M0202T
  Critical Commercial Assays                                                                 
  Gentra Puregene Blood Kit                                        QIAGEN                    Cat\# 158445
  QIAquick PCR Purification Kit                                    QIAGEN                    Cat\# 28104
  MinElute PCR Purficiation Kit                                    QIAGEN                    Cat\# 28004
  QIAQuick gel extraction set                                      QIAGEN                    Cat\# 28115
  EZ DNA Methylation Kit                                           Zymo Research             Cat\# D5001
  FastStart High Fidelity PCR System                               Roche                     Cat\# 3553400001
  AMPure XP for PCR Purification                                   Beckman Coulter           Cat\# A63881
  Quant-It dsDNA Assay Kit, High Sensitivity                       Invitrogen                Cat\# Q33120
  Transposase (TDE1) Nextera DNA Sample Prep Kit                   Illumina                  Cat\# FC-131-1024
  KAPA HiFi HotStart ReadyMix (2x)                                 Kapa Biosystems           Cat\#KK2602
  AMPureXP                                                         Beckman Coulter           Cat\#A63880
  Omega EZNA size select kit                                       Omega                     Cat\#D6488-01
  Deposited Data                                                                             
  Raw and analyzed ATAC data                                       This paper                GEO: GSE128266
  Raw and analyzed methylation data                                This paper                GEO: GSE128267
  Raw and analyzed RNA-seq data                                    This paper                GEO: GSE128268
  Human dendritic cell: ATAC-seq                                   NCBI GEO                  GEO: GSM1565735
  Human corneal epithelial cell: ATAC-seq                          NCBI GEO                  GEO: GSM1662255
  Human fibroblast cell: ATAC-seq                                  NCBI GEO                  GEO: GSM1662258
  Human cardiac smooth muscle cell: ATAC-seq                       NCBI GEO                  GEO: GSM1876021
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###### Highlights

-   Epigenomic landscape of erythropoiesis reveals stage-specific patterns of regulation

-   Epigenomic changes in erythropoiesis are linked to erythroid traits and disease genes

-   Erythroid cells exhibit chromatin accessibility patterns distinct from other cell types
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